B
Beijing Minshu Technology
Allergic rhinitis therapy devices and AI forecasting.
About Beijing Minshu Technology
Minshu Technology is a Beijing-headquartered health technology firm focused on pioneering solutions for allergic rhinitis and respiratory allergy management. Grounded in a blend of medical expertise and smart technology, the company designs and manufactures therapeutic devices intended to reduce the symptoms of nasal allergies while also delivering digital services that help individuals anticipate and manage allergic risk factors. Its product portfolio includes a range of nasal therapy devices engineered for comfort and effectiveness across varying degrees of allergic conditions, catering particularly to children and sufferers of moderate-to-severe symptoms. Beyond physical devices, Minshu Technology has developed a suite of digital tools including a nationwide allergy forecast system, mobile applications, and symptom assessment platforms that harness real-time environmental data to forecast concentrations of pollen, dust mites, fungi, and other common allergens. These tools provide personalized guidance, preventive recommendations, and educational resources to users seeking proactive allergy management. The company also offers professional services such as condition tracking, home self-examinations, treatment guidance, and interfaces that connect users with healthcare providers. In addition to serving individual consumers, Minshu Technology extends its data and analytical capabilities via APIs to partners across industries — from smart home devices and automotive systems to healthcare institutions and government public health planners — enabling integration of allergy risk insights into broader technology ecosystems. Founded by healthcare specialists and experienced professionals, the company combines high-tech innovation with clinical understanding to reshape how allergic diseases are anticipated and treated in everyday life.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 22.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Respiratory, Allergy, Core AI, Non-Invasive medical devices and treatments, Immune System, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Mar 2026 | $20M | $80M | Undisclosed | ↗ |
| SEED✓Equity / VC | Apr 2024 | $0 | — | Assunweige | ↗ |
Growth signals
Latest recorded traffic for Beijing Minshu Technology is 170 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- XAXishan Angels Association
- ASAssunweige
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Minshu Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Minshu Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







